Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:10
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
[31]   Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study [J].
Wang, Yuanqi ;
Shen, Jingxian ;
Feng, Shiting ;
Liang, Ruiming ;
Lai, Jiaming ;
Li, Dongming ;
Peng, Baogang ;
Wang, Zaiguo ;
Huang, Cheng ;
Kuang, Ming .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (12) :2220-2228
[32]   Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus [J].
Zheng, Ninggang ;
Wei, Xiaodong ;
Zhang, Dongzhi ;
Chai, Wenxiao ;
Che, Ming ;
Wang, Jiangye ;
Du, Binbin .
MEDICINE, 2016, 95 (26)
[33]   Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection [J].
Kuang, Xuejun ;
Ye, Jiazhou ;
Xie, Zhibo ;
Bai, Tao ;
Chen, Jie ;
Gong, Wenfeng ;
Qi, Lunan ;
Zhong, Jianhong ;
Ma, Liang ;
Peng, Ningfu ;
Xiang, Bangde ;
Wu, Feixiang ;
Wu, Guobin ;
Ye, Haihong ;
Wang, Changmiao ;
Li, Lunqun .
ONCOLOGY LETTERS, 2018, 16 (04) :4937-4944
[34]   Surgical Resection Versus Transarterial Chemoembolization for BCLC Stage C Hepatocellular Carcinoma [J].
Liu, Po-Hong ;
Hsia, Cheng-Yuan ;
Lee, Yun-Hsuan ;
Hsu, Chia-Yang ;
Huang, Yi-Hsiang ;
Su, Chien-Wei ;
Lee, Rheun-Chuan ;
Lin, Han-Chieh ;
Huo, Teh-Ia .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (04) :404-409
[35]   Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: A nationwide Taiwan database analysis of long-term outcome predictors [J].
Shi, Hon-Yi ;
Wang, Shen-Nien ;
Wang, Shih Chin ;
Chuang, Shih-Chang ;
Chen, Chun-Min ;
Lee, King-Teh .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (05) :487-493
[36]   Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization [J].
Fan, Mi ;
Niu, Tingting ;
Lin, Binwei ;
Gao, Feng ;
Tan, Bangxian ;
Du, Xiaobo .
MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (03)
[37]   Preresection transarterial chemoembolization for hepatocellular carcinoma: An experience with 23 patients [J].
Goel M. ;
Gaikwad V. ;
Dharia T. ;
Kulkarni S. ;
Shetty N. ;
Shrikhande S.V. .
Indian Journal of Gastroenterology, 2014, 33 (5) :432-439
[38]   Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma [J].
YunQuan Luo ;
Yi Wang ;
Han Chen ;
MengChao Wu the Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai China .
Hepatobiliary&PancreaticDiseasesInternational, 2002, (04) :523-526
[39]   Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study [J].
Wang, Lei ;
Ke, Qiao ;
Deng, Manjun ;
Huang, Xin ;
Zeng, Jianxing ;
Liu, Hongzhi ;
Yang, Yuan ;
Zeng, Yongyi ;
Zhou, Weiping ;
Liu, Jingfeng .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (11) :1403-1411
[40]   Difficulty classifications of laparoscopic repeated liver resection in patients with recurrent hepatocellular carcinoma [J].
Kinoshita, Masahiko ;
Kanazawa, Akishige ;
Kodai, Shintaro ;
Shimizu, Sadatoshi ;
Murata, Akihiro ;
Nishio, Kohei ;
Hamano, Genya ;
Shinkawa, Hiroji ;
Tanaka, Shogo ;
Takemura, Shigekazu ;
Tsukamoto, Tadashi ;
Kubo, Shoji .
ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 2020, 13 (03) :366-374